Rhythm Pharmaceuticals (RYTM) Financials

$103.86

$1.66 (1.62%)

As on 11-Sep-2026 11:36EDT

Market cap

$7,074 Mln

Revenue (TTM)

$240 Mln

P/E Ratio

--

P/B Ratio

70.1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	239.92	189.76	130.13	77.43	23.64	3.15
Cost of Revenue	26.39	19.49	13.37	9.30	2.13	0.60
Gross Profit	213.53	170.27	116.76	68.13	21.51	2.56
Operating Expenses	414.16	362.28	382.26	252.48	200.66	172.61
Operating Profit (EBIT)	-200.63	-192.02	-265.50	-184.36	-179.16	-170.06
Other Income	--	--	--	--	3.24	100.45
Profit before Tax	-204.28	-196.04	-260.26	-184.11	-181.12	-69.61
Provision for Tax	1.07	0.50	0.35	0.56	1.96	-1.61
Profit after Tax (Net Income)	-205.35	-196.54	-260.60	-184.68	-181.12	-68.01
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-181.12	-69.61

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	217.30	270.03	164.55	169.76	264.26	284.15
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	96.38	104.23	112.21	107.78	78.41	1.95
Current Liabilities	123.59	105.94	115.52	55.20	39.81	43.43
Total Liabilities	560.85	480.20	392.27	332.75	382.48	329.52

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	10.70	13.28	18.07	24.48	28.25	21.14
Current Assets	426.56	466.92	374.20	308.27	354.24	308.39
Total Assets	560.85	480.20	392.27	332.75	382.48	329.52
Total Debt*	3.68	3.99	3.94	1.26	2.02	2.55
Net Current Assets	302.98	360.97	258.68	253.07	314.43	264.96

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-115.68	-113.88	-136.16	-173.43	-146.00
Cash Flow from Investing Activities	--	-137.15	-48.17	-5.67	28.03	-62.16
Cash from Financing Activities	--	217.96	191.24	74.37	213.83	166.48
Net Cash Inflow / Outflow	--	--	--	--	68.43	-41.68

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-3.07	-2.94	-4.23	-3.12	-3.22	-1.35
Cash EPS ($)	--	-2.92	-4.21	-3.09	-3.19	-1.33
Adjusted Book Value ($)	--	4.04	2.67	2.87	4.69	5.65
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.73	-1.85	-2.30	-3.08	-2.90
Free Cash Flow per Share ($)	--	-1.74	-1.85	-2.30	-3.16	-3.01

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-88.83	-153.52	-84.46	-65.51	-29.81
ROE (%)	-84.27	-90.45	-155.91	-85.10	-66.05	-30.18
ROA (%)	-38.63	-45.05	-71.89	-51.64	-50.88	-26.33
EBIT Margin (%)	-77.44	-92.47	-184.17	-219.85	-744.22	-5,391.85
Net Margin (%)	-85.59	-103.57	-200.27	-238.52	-673.88	-65.64
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	53.51	0.46	0.68	2.28	6.49	89.11
EBIT Growth (%)	-15.28	26.79	-40.79	3.24	-3.45	-24.52
Net Profit Growth (%)	-12.17	24.58	-41.11	-1.97	-166.32	47.98
EPS Growth (%)	-4.67	0.31	-0.36	0.03	-1.38	0.54
Book Value Growth (%)	51.03	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-36.42	-13.23	-14.74	-9.05	-7.38
Price / Book Value	70.13	26.51	20.96	16.03	6.20	1.77
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-12.65	-38.90	-13.15	-14.53	-7.51	-1.24
Close Price ($)	111.03	107.04	55.98	45.97	29.12	9.98
High Price ($)	122.20	122.20	68.58	50.28	30.98	43.26
Low Price ($)	62.84	45.91	35.17	15.50	3.04	8.44
Market Cap ($ Cr)	7,073.86	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.01	0.02	0.01	0.01	0.01
Short term debt to equity ratio	0.00	0.00	0.01	0.00	0.00	0.00
Current Ratio	3.45	4.41	3.24	5.58	8.90	7.10
Quick Ratio	3.20	4.16	3.08	5.43	8.83	7.10
Interest Coverage	-10.05	-8.52	-11.63	-12.25	-33.82	-1.69

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	16.84	13.74	14.23	19.20	26.33	32.50
Asset Turnover	0.45	0.43	0.36	0.22	0.07	0.01
Receivable days	--	42.92	46.85	49.75	56.01	59.35
Inventory Days	--	416.87	373.84	226.58	259.25	67.68
Payable days	--	246.18	235.15	190.09	901.91	3,243.04
Cash Conversion Cycle	--	213.61	185.54	86.24	-586.65	-3,116.01

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.